Lupin has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules, 30 mg & 90 mg strengths from the United States Food and Drug Administration (FDA). Lupin Pharmaceuticals (LPI), the company’s US subsidiary would commence marketing the product shortly. LPI currently markets and promotes Antara Capsules, 43 mg & 130 mg strengths. The new drug would be manufactured by Lupin.
Epic Research
Tuesday, October 22, 2013
Epic Update : Lupin
Labels:
Best Stock Tips,
Best Tips For Intraday,
Bullion Tips,
Commodity Tips,
equity tips,
Equity Tips Free Trial,
Forex Tips,
Forex Tips MCX Tips,
Free Trial,
MCX Tips,
NCDEX Tips,
NCDEX Tips.,
Penny Stock Tips,
share market,
share tips,
share tips india,
stock tips,
stock tips india,
Stock Trading Tips.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment